Chryslaine Rodríguez-Tanty | Chemistry Award | Best Researcher Award

Posted on by ScienceFather

Mrs. Chryslaine Rodríguez-Tanty | Chemistry Award | Best Researcher Award

Mrs. Chryslaine Rodríguez-Tanty, Centro de Neurociencias de Cuba, Cuba

Mrs. Chryslaine Rodríguez-Tanty is a prominent researcher focused on Alzheimer’s disease and neurodegeneration. She is known for her work on Amylovis-201, a dual-target ligand that acts as an anti-amyloidogenic compound and a potent σ1 receptor agonist. Her research demonstrates Amylovis-201’s effectiveness in inhibiting Aβ peptide aggregation and its neuroprotective effects through σ1 receptor activation. Chryslaine’s contributions are pivotal in developing innovative therapies for neurodegenerative diseases. 🧠💊🔬

Publication profile

Scopus

Google Scholar

Research Focus

Chryslaine Rodríguez-Tanty is primarily focused on the development of therapeutic agents targeting neurodegenerative diseases and other conformational disorders. Her work includes the study of amyloid structures, drug discovery for Alzheimer’s disease, and the development of chemical chaperones. She has also contributed to research on polymorphic amyloid structures in diabetes and the synthesis of peptide-oligonucleotide hybrids. Chryslaine’s research spans organic chemistry, biochemistry, and pharmacology, aiming to create innovative treatments for complex diseases. 🧬🧠💊🔬

Publication Top Notes

  • Drug development in conformational diseases: A novel family of chemical chaperones that bind and stabilise several polymorphic amyloid structures – PLoS One 10 (9), e0135292, 2015 (Cited by: 30) 🧬💊
  • Diabetes Drug Discovery: hIAPP1–37 Polymorphic Amyloid Structures as Novel Therapeutic Targets – Molecules 23 (3), 686, 2018 (Cited by: 27) 🩺🍬
  • [18F] Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, in Silico, in vitro and in vivo Evaluations – Current Radiopharmaceuticals 12 (1), 58-71, 2019 (Cited by: 17) 🧠🔬
  • Alternative Procedures for the Synthesis of Methionine‐Containing Peptide− Oligonucleotide Hybrids – European Journal of Organic Chemistry 2000 (13), 2495-2500, 2000 (Cited by: 16) 🧬🧪
  • A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer’s disease – Bioorganic & Medicinal Chemistry 28 (20), 115700, 2020 (Cited by: 14) 🧠💊
  • Use of a chimeric synthetic peptide from the core p19 protein and the envelope gp46 glycoprotein in the immunodiagnosis of HTLV-II virus infection – Preparative Biochemistry and Biotechnology 33 (1), 29-38, 2003 (Cited by: 10) 🦠🧬
  • Introduction of an immunochemical label in a cytidine analogue – Nucleosides, Nucleotides & Nucleic Acids 14 (1-2), 219-228, 1995 (Cited by: 10) 🧪🔬
  • 2′, 3′-Didehydro-3′-deoxythymidine N-methyl-2-pyrrolidone solvate (D4T· NMPO) – Acta Crystallographica Section C: Crystal Structure Communications 56 (5), 2000 (Cited by: 9) 🔬🧬
  • Synthesis of 5-Methyl-2′-O-Deoxycytidine Analogs to Determine Monoclonal Antibody Specificity in the Recognition of the 6-(p-Bromobenzoylamino) Caproyl – Nucleosides & Nucleotides 16 (4), 455-467, 1997 (Cited by: 8) 🧪🔬
  • Identificación y caracterización in silico de la zona de interacción entre el péptido beta-amiloide y compuestos derivados del naftaleno – Revista CENIC. Ciencias Químicas 43, 2012 (Cited by: 7) 🧠🔍

Thirumavalavan Munusamy | Inorganic Chemistry Award | Best Researcher Award

Posted on by ScienceFather

Dr. Thirumavalavan Munusamy | Inorganic Chemistry Award | Best Researcher Award

Dr. Thirumavalavan Munusamy, Saveetha Engineering College, India

Dr. Thirumavalavan Munusamy is a distinguished chemist with over two decades of international experience in inorganic chemistry, nanotechnology, and environmental science. Holding a Ph.D. from the University of Madras, India, his expertise encompasses the synthesis and characterization of complex compounds, as well as extensive research in nanomaterials and environmental applications. Notable for his contributions, he has received numerous awards and grants, published in prestigious journals, and served as an editorial board member for several esteemed publications. As a dedicated educator, he has guided numerous students and contributed significantly to the academic community. 🧪📚

Publication Profile

Scopus

Orcid

Google Scholar

🎓 Academic Journey

Dr. M. Thirumavalavan embarked on his academic voyage with a Bachelor’s degree in Chemistry from Loyola College, Chennai, followed by a Master’s from C.A.H. College, Melvisharam. He attained his Ph.D. in Inorganic Chemistry from the University of Madras, delving into the synthesis and characterization of novel macrobicyclic tricompartmental ligands and their metal complexes.

🏆 Awards and Recognitions

Dr. Thirumavalavan’s contributions have been acknowledged globally, from being recognized in “Who’s Who in the World” to receiving prestigious fellowships such as NSC, Taiwan, and FCT, Portugal. He’s served as an editorial board member for esteemed journals like Nanomedicine and Nanotechnology Journal and has been lauded by the International Biographical Centre, Cambridge.

👨‍🏫 Teaching

Alongside his research pursuits, Dr. Thirumavalavan has been a mentor and educator, guiding numerous master’s and doctoral students. He’s adept at handling classes in nano-biotechnology, environmental sciences, and chemistry for biomedical engineering.

🔬 Research Focus

Dr. M. Thirumavalavan’s research primarily centers around the synthesis and application of nanomaterials for environmental remediation and catalytic processes. He specializes in the development of cellulose-based adsorbents, chitosan/ZnO nanocomposites, and mesoporous silica materials for heavy metal ion adsorption and photocatalytic degradation. His work extends to exploring the structural and functional properties of these materials, aiming to address challenges in water pollution and environmental sustainability. With a keen interest in innovative solutions, he continually explores novel approaches to tackle pressing environmental concerns through advanced materials science.

Publication Top Notes